New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 22, 2013
05:26 EDTAMPEAmpio announces active IND for Optina for treatment of DME
Ampio Pharmaceuticals announced that the FDA has accepted the company's IND for Optina for the treatment of Diabetic Macular Edema, or DME. Ampio plans to commence enrollment in a clinical trial in Q1. The FDA granted Optina 505 b 2 status in July, 2012. Drugs designated under this pathway can be approved on a single trial.
News For AMPE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 19, 2014
07:11 EDTAMPESociety for Free Radical Biology and Medicine to hold annual meeting
Subscribe for More Information
November 12, 2014
09:21 EDTAMPEOn The Fly: Pre-market Movers
Subscribe for More Information
08:12 EDTAMPEAmpio's Ampion vials will be manufactured in 1Q15
Subscribe for More Information
08:11 EDTAMPEAmpio updates status of clinical trials and manufacturing facility
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use